aggregate procedures has quickened in other countries, and the U.S. is no longer alone in allowing a form of class, representative, or group litigation, or in consolidating similar litigation. 4 Aggregation of cases has a direct impact on the relationship between client and attorney and on the fee arrangements between them. Large numbers of lawyers are likely to be involved, and many functions traditionally handled by an individual attorney have to be delegated to groups or committees within a consortium of the attorneys whose cases have been aggregated. Individual clients also become part of an aggregate group represented by layers of attorneys rather than their individual attorney. 5 As a result, clear lines as to attorney compensation for service to an individual client may be blurred as a consortium of lawyers takes on the class, group, or consolidated representation.
American courts are now grappling with issues of attorney representation and compensation that arise out of the changed attorney-client relationship in aggregate litigation. Little attention has been given to these issues in other countries which are not as advanced in aggregate litigation and whose concerns have tended to focus on how to limit the size and scope of cases to prevent them from becoming unmanageable and unfair. In addition, most other countries have eschewed entrepreneurial conduct by attorneys and contingent fees. These features of American practice have made representation and compensation issues more pressing in the U.S. Nevertheless, the growing experience of American courts in dealing with these issues should be of interest to other countries as they move towards greater aggregate litigation.
I. JUDICIAL SUPERVISION OF ATTORNEY REPRESENTATION AND COMPENSATION IN THE U.S.
American courts in individual cases have little authority over the conduct of attorney representation and compensation. Rules of professional conduct in each state govern attorney performance and fees. Violations of those rules are within the purview of the state bar disciplinary apparatus, and a court in an individual case is not empowered to supervise those matters unless there is a direct violation of proper procedures before it. The terms of representation and compensation are established by contract between the attorney and client and are not generally reviewable by the court. A judge in an individual case will often not know the terms of the representation in the attorney-client contract and will never have occasion to consider them. The computation and collection of the attorney's fee at the end of the litigation usually takes place without any involvement of the court. Only if there is a dispute over the attorney's fees might a court be called on for review, either on a motion to the original court or in a separate action possibly in another court.
An exception to the "judicial hands-off" character of attorney fees may arise if a prevailing party seeks the recovery of attorney's fees in the case. The "American rule" that each party bears his own attorney's fees is contrary to the "loser pays" rule in most other countries. 6 However, there are exceptions to the rule if fee-shifting is provided for in a statute 7 or if a "common fund" is created by the litigation for the benefit of other persons 8 (which is a feature of class actions and aggregate litigation but not most individual cases). In those situations the trial court is called upon to determine the amount of the attorney's fees.
There is another situation is which an American court might have supervisory authority to review attorney's fees -when there is a contingent fee contract. A sizable percentage of American lawsuits are undertaken by attorneys on a contingent fee under which only if the plaintiff wins will they be entitled to a fee of a specified percentage of the client's recovery.
9 "Contingency fee agreements are of special concern to the courts" and thus subject to heightened review. 10 The inherent power of a court generally to enforce lawyers' professional responsibility and regulate the bar has been said to include the specific right to review the reasonableness of contingency fees.
11 A court's power to regulate contingency fees stems from a lawyer's ethical duty to charge a reasonable fee, 12 and thus a court's power to monitor contingency fees for reasonableness has been recognized. 13 The 14 Nevertheless, there is still disagreement as to the scope of a court's review power, and it is urged that deference should be given to the right of attorneys and clients to contract for a particular fee percentage. 15 
II. SUPERVISION OF ATTORNEY'S FEES IN CLASS ACTIONS
There is much greater judicial supervision of attorney's fees in American class actions. First, class action settlements must be approved by the court.
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A high percentage of cases that are certified as class actions are settled, and settlements generally provide for the payment of attorney's fees to plaintiff's counsel (either stated as an amount or percentage or left up to the judge to determine). Judges have been admonished by rule and case law to provide an intensive review of attorney's fees since the payment of attorney's fees generally reduces the recovery for class members. Second, in the rare case in which a class action is actually tried and there is a litigated, as opposed to settled, judgment, the court does not have the express power to supervise the amount and payment of attorney's fees, but can in reality play that role. 17 Class actions often involve statutory exceptions to the American rule that authorize fee-shifting to the prevailing party, and thus the court will determine the amount of the fee. In addition, in certifying the class the court must determine that "the representative parties will fairly and adequately protect the interests of the class,"
18 and that might well include review of the reasonableness of a contingent fee contract.
Class actions are a paradigm for judicial supervision of attorney's fees in American aggregate litigation. However, not all-aggregate litigation can qualify as a class action, and it is in such cases that there has been uncertainty as to a court's power to reject or "cap" attorney's fees despite a contingent fee contract. The Vioxx litigation provides an contracts. Indeed, this power is reflected in the contingent fee contract's providing a fixed percentage for counsel, 'or as allowed by law.'"); confirms that no empirical evidence of a market failure for attorney's fee contracts exists in mass tort litigation that is not a class action…. Each plaintiff in a non-class MDL possesses the opportunity at the outset of his case to seek and hire an attorney who offers the best combination of quality, efficiency, price, and record of success. Courts should enforce fairlynegotiated fee contracts that at inception take into account the possibility of MDL proceedings and factor in whatever efficiencies they may bring.").
16 Fed. R. Civ. Pro. 23(e)("The claims, issues, or defenses of a certified class may be settled, voluntarily dismissed, or compromised only with the court's approval."); Fed. R. Civ. Pro. 23(e)(2)("If the proposal would bind class members, the court may approve it only after a hearing and on finding that it is fair, reasonable, and adequate.").
17 "Regardless of whether a fee agreement exists, the amount of attorneys' fees in class actions must ultimately be determined by the court. This is true whether the case goes to trial or results in a settlement. Courts have generally used two methods to set the amount of fees to be awarded to class counsel: the percentage of the fund method and the 'lodestar' approach." Klonoff, Class Actions and Other Multi-Party Litigation 200 (1999 19 It was removed from the market in 2004 after evidence surfaced that it increased the risk of heart attacks and strokes. Thousands of individual suits and numerous class actions were filed against Merck in state and federal courts throughout the country alleging product liability, tort, fraud, and warranty claims.
On February 16, 2005, the Panel on Multidistrict Litigation transferred suits representing the claims of over 4,000 plaintiffs that had been filed in federal courts against Merck (ultimately increased to some 20,000) to the U.S. Court for Eastern District of Louisiana. The Multidistrict Litigation (MDL) device, created in the 1960's in response to the crisis caused by electrical equipment price-fixing cases flooding the federal courts, 20 permits a panel of federal judges to transfer cases pending in federal courts with "common questions of fact" to a single federal judge "for coordinated or consolidated pretrial proceedings."
21 Coordinated discovery was the principal benefit, insuring that all the cases could share discovery that would be rationally scheduled and avoid wasteful repetition. But over the years the "transferee judge" to whom cases were transferred came to assert a more prominent managerial role over the litigation, making dispositive pretrial rulings on motions including class certification 22 and encouraging settlement.
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Thus the MDL has become a principal form of aggregate litigation, enabling the federal court system to transfer and consolidate like cases before a single judge who has a principal responsibility for accomplishing a settlement. 24 "One of the values of multidistrict proceedings is that they bring before a single judge all of the cases, parties, and counsel comprising the litigation. They therefore afford a unique opportunity for the negotiation of a global settlement. Experience shows that few cases are remanded for trial; most multidistrict litigation is settled in the transferee court. In managing the litigation, therefore, the transferee judge should take appropriate steps to make the most of this opportunity and facilitate the settlement of the federal and any related state cases." MANUAL FOR COMPLEX LITIGATION (THIRD) § 31.132 (1995).
The Vioxx transferee judge, Judge Eldon E. Fallon, set about bringing the Vioxx litigation to a stage where a settlement was possible, overseeing coordinated discovery and ordering "bellwether trials" of a handful of selected cases. 25 Out of the hundreds of attorneys who had individual cases, a small number were appointed to serve in such positions as Lead Counsel, Plaintiff's Liaison Counsel, Plaintiffs' Steering Committee, and Negotiating Plaintiff Counsel. Plaintiffs' motion for a class action as to damage claims was denied by Judge Fallon on the ground that the condition and circumstances surrounding the taking of the drug by each person were so individualized and based on potentially differing state laws that the "predominance of common questions" requirement could not be met. 26 
IV. THE VIOXX GLOBAL SETTLEMENT
At the court's encouragement, negotiations with the defendant Merck took place over an extended period. Settlement was complicated because an even larger number of Vioxx cases were pending in state courts (some 30,000), and the federal transferee court had no jurisdiction over them. However, representative counsel from the state cases were included in the negotiations, and on November 9, 2007, a global settlement was announced between Merck and the Executive Committee of the Plaintiffs' Steering Committee in the federal MDL and representatives of plaintiffs' counsel in the coordinated proceedings in the three state courts where most of the state cases were pending (New Jersey, California, and Texas).
27 Merck agreed to pay $4.85 billion to be paid pursuant to a complex administrative and claims procedure. 28 Judge Fallon, sitting with the coordinated proceedings judges from New Jersey and California, received the agreement in open court. The agreement settled the claims in all Vioxx cases then pending in federal and state courts, and established an administrative framework, with Judge Fallon as Chief Administrator, and Special Masters to be appointed by him, to oversee the settlement. 29 The claims process was to be administered by a private claims consultant company. 25 Bellwether trials are trials of individual cases selected by the judge in consultation with counsel to provide each side with a realistic view of how a jury would decide a range of cases within the aggregated litigation and thus assist them in reaching a settlement amount for all cases. . 2003 ) (finding individual issues such as injury, causation, learned intermediary defense, and comparative fault prevented predominance). However, he deferred ruling on class claims by "third-party purchasers" (such as medical insurers) and for "medical monitoring," which claims were not included in the settlement of damage actions. 27 Together the MDL and three state coordinated proceedings included more than 95% of the plaintiffs in Vioxx cases. This was a unique approach to resolving the problem of related cases pending in both federal and state courts. It could only have come about through coordination and collaboration between the representatives of the federal and state plaintiffs' counsel as well as between Judge Fallon and the state court judges. One reason for its success, in contrast to the asbestos global settlement which the U.S. Supreme Court had struck down in Amchem, 30 was its limited scope. It applied only to pending cases filed by persons who claimed to have suffered injuries from taking the drug. Unlike asbestos, a drug like Vioxx has a short latency period, and there was virtually no likelihood that, at the time of settlement, persons who took the drug had not yet manifested injury. Unlike a class action settlemtn, it was limited to pending cases and did not attempt to settle cases filed after the date of the settlement. Merck ran the risk of having to try or settle new cases filed after the date of settlement, but because of the short latency period and the passage of some three years since the drug was taken off the market, it was not expected that the number would be large. In order for Merck to have the security of settling most of the likely claims against it, the agreement required that 85% of the plaintiffs in pending cases would enroll in the settlement in order for it to take effect. 31 This is a common provision in global settlements, and was not a problem here since more than 95% of plaintiffs ultimately enrolled in the settlement. 32 
V. THE VIOXX CAPPING OF ATTORNEY'S FEES
As often occurs in settlements of aggregate litigation, the allocation of plaintiffs' attorney's fees among large numbers of attorneys who had individual cases was an issue. The settlement agreement provided for a Fee Allocation Committee of plaintiffs' attorneys to make recommendations to the judge as to fees to be paid to individual attorneys and as to the amount of fees to be deposited in a Common Benefit Fund. 33 But before the allocation of fees was finally made, Judge Fallon, acting sua sponte, entered an order capping all contingent fees at 32%, so that no attorney representing a Vioxx claimant could collect more than 32% of the claimant's settlement award. 34 He claimed inherent judicial authority, as well as authority under the settlement agreement and due to the nature of the MDL proceeding, to impose a cap to insure that the claimants were properly compensated. Citing case law and state statutes that limited contingent fees, he determined that 32% was a reasonable percentage. He noted that "this reduction will not result in a paltry award" since 32% of the settlement fund of $4.85 billion would be $1.55 billion for all attorneys. 35 A group of attorneys primarily from Texas and Louisiana (called the Vioxx Litigation Consortium or VLC), who had contingent fee contracts with their individual clients in excess of 32% (many of them at 40%), challenged this order.
In a motion for a rehearing, the VLC attorneys argued that the court lacked authority to supervise, and particularly to cap, contingent fees. They pointed out that this was not a class action, where a court must approve a settlement, and that the MDL statute has no comparative requirement: "Class action rules do not become applicable simply because a large number of cases settle. Individual differences remain, not only as to the characteristics of each individual claim, but also as to the relationship between each plaintiff and his attorney." 36 The policy reasons for court review of attorney's fees in class actions, they argued, do not apply to this case transferred and consolidated under MDL: "Unlike a class action, there are no 'nonparty' or 'absentee' plaintiffs in this MDL. Each plaintiff is personally represented by the attorney of his choice." 37 The terms of a contingent fee, they maintained, are particularly a matter for the attorney and client, and imposition of this cap was unreasonable and could ultimately lead to clients being unable to engage skilled attorneys who would be willing to take the risk of financing a long and difficult piece of litigation.
This raises a question as to whether the analogy to a class action is valid or necessary for an MDL judge in a consolidated action to have the authority to supervise and review attorney's fees. Judge Fallon had used the phrase "quasi-class action" to describe MDLs in invoking the court's equitable powers to review the Vioxx Resolution Program.
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Other courts have used the "quasi-class action" analogy to confer equitable authority to review attorney's fees. 39 They point out that policies supporting monitoring contingent fees in class actions also apply to MDL consolidations which have a large number of plaintiffs subject to one settlement matrix, use court-appointed special masters to help administer the settlement, create a large escrow fund, and involve other court interventions. 40 The argument seems to be that the MDL form of aggregate litigation has so altered the traditional single-party lawsuit through a high degree of court supervision and aggregate procedures that judicial supervision of attorneys' fees, a la class actions, is authorized.
The MDL statute itself provides some support for this position. It directs the MDL panel to centralize cases only when it is possible to strike a balance between efficiency and fairness. 41 Since the Panel exerts no oversight once the cases are transferred, it is up to the transferee judge to use equitable authority to insure that the aggregate procedures achieve the proper balance. The transferee court is encouraged to be innovative, as "the complexity, diversity, and volume of mass tort claims require adapting traditional procedures to new contexts." 42 Thus the argument is that whatever the strength of the class action analogy, consolidated MDL cases warrant judicial supervision of attorney's fees to protect the interests of the claimants against undue erosion of their recoveries by excessive attorneys fees.
Judge Fallon saw the interests of the claimants to be adverse to that of the attorneys as to attorney's fees. "District courts," he said, "necessarily retain the authority to examine attorney fees sua sponte because the attorneys' interests in this regard are in conflict with those of their clients." 43 Two MDL cases also premised judicial review of contingent fees on the proposition that plaintiffs' counsel have a built-in conflict of interest. 44 The VLC attorneys saw a court's legitimate concerns as much more limited, pointing out that two circuit court cases permitting courts to monitor contingent fees had been in the context of seamen and children, who required special protection. 45 They focused on a Fifth Circuit case that reversed a sanction against attorneys and its language that a federal court's inherent powers consist of those "necessary" for the courts to manage their affairs and extend only to litigation before the court, or, in the case of a sanction, to disobedience of the court's orders. 46 If the mix of inherent judicial powers, analogy to class actions, the MDL statute, and the altered status of the attorney-client relationship under MDL consolidation is enough to justify Judge Fallon's capping order, the question is how far that authority goes. Is it present in all MDL consolidations (even though the statute does not specifically provide for it)? Is it present in all consolidated cases since they necessarily involve replacing the primary representation of the individual's attorney with an altered aggregate form of representation? Or is it present only in some MDL and ordinary consolidation cases in which there are special concerns over a conflict of interest between attorneys and clients or special needs for a more expansive form of case management? These questions might be answered in an appeal to the 5 th Circuit.
VI. CONCLUSION
Aggregate litigation -whether in class actions or consolidation of individual casesinvariably impacts the individual attorney-client relationship. What was once understood between the attorney and client as to the attorney's responsibilities and expected functions may be altered as committees of attorneys assume principal roles in the litigation. Nevertheless, in consolidated cases the individual attorney-client relationship remains, with attorneys continuing to perform services on behalf of their individual clients (which may or may not ultimately benefit the aggregate plaintiffs). The fact that under MDL, cases must be transferred back to their original courts for individual resolution 47 signifies that the individual attorney-client relationship remains. However, return of cases is rare, and once there is a settlement in the MDL court, as in Vioxx, the aggregate interests take on special importance. The experience of the Vioxx consolidated MDL case, with its unique global settlement extending across jurisdictional lines and with Judge Fallon's capping order as to contingent fees, provides a crucible for testing the parameters of judicial supervision in aggregate litigation. If the capping order is upheld on appeal, it will confirm greater judicial authority over attorney representation and compensation in the management of aggregate litigation.
